Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study - 18/10/24
Doi : 10.1016/j.jaad.2024.06.072
Emily E. Granger, MD a, Nina A. Ran, MD, MS b, Morgan K. Groover, MD c, Shlomo A. Koyfman, MD d, Allison T. Vidimos, RPh, MD e, Ashley Wysong, MD, MS f, David R. Carr, MD, MPH g, Kathryn T. Shahwan, MD g, Kelsey E. Hirotsu, MD h, John A. Carucci, MD, PhD i, Joi B. Carter, MD j, Javier Cañueto, MD k, Fabio Muradás Girardi, MD, MSc l, Aaron R. Mangold, MD m, Divya Srivastava, MD n, David G. Brodland, MD o, John A. Zitelli, MD o, Tyler J. Willenbrink, MD o, Emily S. Ruiz, MD, MPH b, ⁎ 
a Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland
b Department of Dermatology, Brigham and Women’s Hospital, Boston Massachusetts
c Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts
d Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio
e Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
f Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska
g Department of Dermatology, The Ohio State University Medical Center, Columbus, Ohio
h Department of Dermatology, Stanford School of Medicine, Palo Alto, California
i Department of Dermatology, New York University School of Medicine, New York, New York
j Department of Dermatology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
k Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Salamanca
l Department of Head and Neck Surgery, Ana Nery Hospital, Santa Cruz do Sul, RS, Brazil
m Department of Dermatology, Mayo Clinic Arizona, Scottsdale, Arizona
n Department of Dermatology, University of Texas Southwestern School of Medicine, Dallas, Texas
o Zitelli and Brodland P.C., Pittsburgh, Pennsylvania
∗Correspondence to: Emily S. Ruiz, MD, MPH, Brigham and Women’s Hospital, 1153 Centre Street, Suite 4J, Boston, MA 02130Brigham and Women’s Hospital1153 Centre StreetSuite 4JBostonMA02130
Key words : cutaneous squamous cell carcinoma, metastasis, nonmelanoma skin cancer, oncology, outcomes, recurrence
| Funding sources: Supported in part by the American College of Mohs Surgery (ACMS) Foundation. |
|
| IRB approval status: Reviewed and approved by all twelve institutions. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 91 - N° 5
P. 957-960 - novembre 2024 Retour au numéro
Article précédent
- Targeted immunotherapy for moderate-to-severe palmoplantar pustulosis: A network meta-analysis of randomized controlled trials
- Ya-Chu Tsai, Francis LT. Hsu, Tsen-Fang Tsai
- Differences in skin cancer surveillance among patients with nonmelanoma skin cancer by race: A retrospective cohort study
- Marta Taye, Kalina T.L. Machado, Travis Blalock, Loren D. Krueger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?